Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (4592)	7/24/1998 6:15:00 PM
From: Anthony Wong	Respond to of 9523

Pfizer Inc. Maintained 'Buy' at Salomon Smith Barney & Gerard Klauer Bloomberg News July 24, 1998, 2:46 a.m. ET Princeton, New Jersey, July 24 (Bloomberg Data) -- Pfizer Inc. (PFE US) was maintained ''buy'' by analyst Christina Heuer at Salomon Smith Barney. The 12-month target price is $155.00 per share. -- Andrew Bekoff in Princeton, New Jersey, (609)279-3652 Pfizer Inc. Reiterated 'Buy' at Gerard Klauer Bloomberg News July 24, 1998, 3:29 p.m. ET Princeton, New Jersey, July 24 (Bloomberg Data) -- Pfizer Inc. (PFE US) was reiterated ''buy'' by analyst Cynthia A. Beach at Gerard Klauer Mattison & Co. The 12-month target price is $140.00 per share. -- Andrew Bekoff in Princeton, New Jersey, (609)279-3652

To: Anthony Wong who wrote (4592)	7/25/1998 5:57:00 PM
From: flickerful	Respond to of 9523

<<Henry McKinnell, president of Pfizer Pharmaceuticals Group, told Wall Street analysts that Japan had promised to grant an accelerated review of the company's application to market the drug in that country, one of the world's biggest markets for prescription drugs.>> i am reminded of our earlier exchange on this subject...contemporary pressure has indeed extracted from the government a responsiveness ( apparently) historically without precedent. interesting, at the very least. randy